Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Arginase as a target for treatment of myocardial ischemia-reperfusion injury.

Tratsiakovich Y, Yang J, Gonon AT, Sjöquist PO, Pernow J.

Eur J Pharmacol. 2013 Nov 15;720(1-3):121-3. doi: 10.1016/j.ejphar.2013.10.040. Epub 2013 Oct 29. Review.

PMID:
24183975
2.

Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase.

Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L.

FASEB J. 2003 Dec;17(15):2328-30. Epub 2003 Oct 16.

3.

Arginase inhibition mediates cardioprotection during ischaemia-reperfusion.

Jung C, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J.

Cardiovasc Res. 2010 Jan 1;85(1):147-54. doi: 10.1093/cvr/cvp303. Epub .

4.

Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.

Gonon AT, Jung C, Katz A, Westerblad H, Shemyakin A, Sjöquist PO, Lundberg JO, Pernow J.

PLoS One. 2012;7(7):e42038. doi: 10.1371/journal.pone.0042038. Epub 2012 Jul 31.

5.

Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?

Pernow J, Jung C.

Cardiovasc Res. 2013 Jun 1;98(3):334-43. doi: 10.1093/cvr/cvt036. Epub 2013 Feb 14. Review.

6.

TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury.

Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, Chilian WM, Zhang C.

Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1269-75. Epub 2007 Apr 5.

7.

Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.

Stühlinger MC, Conci E, Haubner BJ, Stocker EM, Schwaighofer J, Cooke JP, Tsao PS, Pachinger O, Metzler B.

Cardiovasc Res. 2007 Jul 15;75(2):417-25. Epub 2007 May 5.

8.

The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.

Pernow J, Wang QD.

Acta Physiol Scand. 1999 Oct;167(2):151-9.

PMID:
10571551
9.

Arginase inhibition improves coronary microvascular function and reduces infarct size following ischaemia-reperfusion in a rat model.

Grönros J, Kiss A, Palmér M, Jung C, Berkowitz D, Pernow J.

Acta Physiol (Oxf). 2013 Jun;208(2):172-9. doi: 10.1111/apha.12097. Epub 2013 Apr 15.

10.

Arginase blockade protects against hepatic damage in warm ischemia-reperfusion.

Jeyabalan G, Klune JR, Nakao A, Martik N, Wu G, Tsung A, Geller DA.

Nitric Oxide. 2008 Aug;19(1):29-35. doi: 10.1016/j.niox.2008.04.002. Epub 2008 Apr 14.

11.

Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.

Gonon AT, Erbas D, Bröijersén A, Valen G, Pernow J.

Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1767-74. Epub 2003 Dec 23.

12.

Arginase regulates red blood cell nitric oxide synthase and export of cardioprotective nitric oxide bioactivity.

Yang J, Gonon AT, Sjöquist PO, Lundberg JO, Pernow J.

Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):15049-54. doi: 10.1073/pnas.1307058110. Epub 2013 Aug 26.

13.

Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus.

Kövamees O, Shemyakin A, Pernow J.

PLoS One. 2014 Jul 29;9(7):e103260. doi: 10.1371/journal.pone.0103260. eCollection 2014.

14.

Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.

Tsai SK, Lin SM, Huang CH, Hung WC, Chih CL, Huang SS.

Life Sci. 2004 Dec 24;76(6):651-60.

PMID:
15567190
15.
16.

Critical timing of L-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms.

Liang F, Gao E, Tao L, Liu H, Qu Y, Christopher TA, Lopez BL, Ma XL.

Cardiovasc Res. 2004 Jun 1;62(3):568-77.

17.
18.

[Biochemical mechanisms of the cardioprotective effect of the K(ATP) channels opener flocalin (medicinal form) in ischemia-reperfusion of myocardium].

Strutyns'kyĭ RB, Kotsiuruba AV, Rovenets' RA, Strutyns'ka NA, Iagupols'kyĭ IuL, Sagach VF, Moĭbenko OO.

Fiziol Zh. 2013;59(4):16-27. Ukrainian.

PMID:
24175472
19.

Nitric oxide signaling in ischemic heart.

Maulik N, Engelman DT, Watanabe M, Engelman RM, Maulik G, Cordis GA, Das DK.

Cardiovasc Res. 1995 Oct;30(4):593-601.

PMID:
8575007
20.

Clematichinenoside attenuates myocardial infarction in ischemia/reperfusion injury both in vivo and in vitro.

Zhang R, Fang W, Han D, Sha L, Wei J, Liu L, Li Y.

Planta Med. 2013 Sep;79(14):1289-97. doi: 10.1055/s-0033-1350671. Epub 2013 Aug 8.

PMID:
23929248
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk